William Blair downgraded Cardinal Health Inc. (NYSE:CAH) from Outperform to Market Perform in a statement released earlier today.
- Updated: April 20, 2017
William Blair has downgraded Cardinal Health Inc. (NYSE:CAH) from Outperform to Market Perform in a statement released on 4/20/2017.
Boasting a price of $73.16, Cardinal Health Inc. (NYSE:CAH) traded 1.09% higher on the day. With the last stock price close down -3.39% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range. Cardinal Health Inc. has recorded a 50-day average of $81.39 and a two hundred day average of $75.88. Volume of trade was up over the average, with 4,581,909 shares of CAH changing hands over the typical 2,203,820
With a total market value of $0, Cardinal Health Inc. has price-earnings ratio of 17.65 with a one year low of $62.70 and a one year high of $87.85 .
A total of 15 equity analysts have released a ratings update on CAH. Seven equity analysts rating the company a strong buy, five equity analysts rating the company a buy, seven equity analysts rating the company a hold, zero equity analysts rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $91.93.
Brief Synopsis About Cardinal Health Inc. (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.